BKD:NYE-Brookdale Senior Living Inc (USD)

COMMON STOCK | Medical Care Facilities |

Last Closing

USD 6.68

Change

0.00 (0.00)%

Market Cap

USD 1.61B

Volume

1.95M

Analyst Target

USD 4.00
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Brookdale Senior Living Inc. owns, manages, and operates senior living communities in the United States. It operates in three segments: Independent Living, Assisted Living and Memory Care, and Continuing Care Retirement Communities (CCRCs). The Independent Living segment owns or leases communities comprising independent and assisted living units in a single community that are primarily designed for middle to upper income seniors. The Assisted Living and Memory Care segment owns or leases communities consisting of freestanding, multi-story communities and freestanding, single-story communities, which offer housing and 24-hour assistance with activities of daily living for the Company's residents. This segment operates memory care communities for residents with Alzheimer's and other dementias. The CCRCs segment owns or leases communities that provides various living arrangements, such as independent and assisted living, memory care, and skilled nursing; and services to accommodate various levels of physical ability and healthcare needs. It manages communities on behalf of others. The company was incorporated in 2005 and is headquartered in Brentwood, Tennessee.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-06-07 )

Largest Industry Peers for Medical Care Facilities

Symbol Name Price(Change) Market Cap
HCA HCA Holdings Inc

N/A

USD 90.60B
THC Tenet Healthcare Corporation

N/A

USD 15.37B
UHS Universal Health Services Inc

N/A

USD 12.76B
EHC Encompass Health Corp

N/A

USD 12.18B
DVA DaVita HealthCare Partners Inc

N/A

USD 10.30B
CHE Chemed Corp

N/A

USD 8.48B
CON Concentra Group Holdings Paren..

N/A

USD 2.77B
ARDT Ardent Health Partners, Inc.

N/A

USD 2.07B
NHC National HealthCare Corporatio..

N/A

USD 1.68B
GRDN Guardian Pharmacy Services, In..

N/A

USD 1.25B

ETFs Containing BKD

ESIE:XETRA iShares MSCI Europe Energ.. 10.90 % 0.00 %

N/A

USD 0.15B
DXSD:F 10.59 % 0.00 %

N/A

N/A
DXSD:XETRA 10.59 % 0.00 %

N/A

N/A
ESIE:LSE iShares MSCI Europe Energ.. 10.41 % 0.00 %

N/A

USD 0.13B
EYED:LSE iShares MSCI Europe Energ.. 9.01 % 0.00 %

N/A

N/A
STNX:SW SPDR® MSCI Europe Energy.. 8.95 % 0.00 %

N/A

USD 0.73B
ENGE:LSE SPDR® MSCI Europe Energy.. 7.90 % 0.00 %

N/A

N/A
CSMIB:SW iShares VII PLC - iShares.. 6.56 % 0.00 %

N/A

N/A
SXEPEX:SW iShares STOXX Europe 600 .. 5.91 % 0.00 %

N/A

USD 0.08B
UC48:LSE UBSs plc - MSCI AC Asia E.. 3.04 % 0.00 %

N/A

USD 0.29B
AJEUAS:SW UBS (Irl) Fund Solutions .. 3.04 % 0.00 %

N/A

N/A
EEI:SW 2.11 % 0.00 %

N/A

N/A
EEIA:SW 2.11 % 0.00 %

N/A

N/A
EWI iShares MSCI Italy ETF 0.00 % 0.47 %

N/A

N/A
CMB1:LSE iShares FTSE MIB UCITS 0.00 % 0.00 %

N/A

USD 0.24B
MIBX:LSE Lyxor UCITS FTSE MIB 0.00 % 0.00 %

N/A

N/A
UC14:LSE UBS (Irl) Fund Solutions .. 0.00 % 0.00 %

N/A

N/A
UC15:LSE UBS (Irl) Fund Solutions .. 0.00 % 0.00 %

N/A

N/A
UC90:LSE UBS (Irl) Fund Solutions .. 0.00 % 0.00 %

N/A

USD 0.01B
FMI:PA Amundi Index Solutions - .. 0.00 % 0.00 %

N/A

USD 0.12B
MIB:PA Lyxor FTSE MIB (DR) UCITS.. 0.00 % 0.00 %

N/A

USD 0.51B
STN:PA SPDR® MSCI Europe Energy.. 0.00 % 0.00 %

N/A

USD 0.73B
ELFC:F Deka EURO iSTOXX ex Fin D.. 0.00 % 0.00 %

N/A

N/A
EXH1:F 0.00 % 0.00 %

N/A

N/A
SPYN:F SSgA SPDR ETFs Europe II .. 0.00 % 0.00 %

N/A

N/A
SXRY:F iShares FTSE MIB UCITS 0.00 % 0.00 %

N/A

USD 0.35B
UIQI:F UBS (Irl) Fund Solutions .. 0.00 % 0.00 %

N/A

USD 0.31B
DBXI:XETRA Xtrackers FTSE MIB UCITS .. 0.00 % 0.00 %

N/A

USD 0.05B
EXH1:XETRA iShares STOXX Europe 600 .. 0.00 % 0.00 %

N/A

USD 0.73B
SPYN:XETRA SPDR® MSCI Europe Energy.. 0.00 % 0.00 %

N/A

N/A
SXRY:XETRA iShares FTSE MIB UCITS 0.00 % 0.00 %

N/A

N/A
UIQI:XETRA UBS (Irl) Fund Solutions .. 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Medical Care Facilities) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 32.80% 92% A 95% A
Dividend Return N/A N/A N/A N/A N/A
Total Return 32.80% 92% A 95% A
Trailing 12 Months  
Capital Gain 0.91% 50% F 47% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 0.91% 50% F 36% F
Trailing 5 Years  
Capital Gain 67.42% 76% C+ 74% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 67.42% 71% C- 66% D+
Average Annual (5 Year Horizon)  
Capital Gain 26.01% 86% B+ 89% A-
Dividend Return 26.01% 86% B+ 87% B+
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 66.88% 23% F 11% F
Risk Adjusted Return 38.89% 73% C 57% F
Market Capitalization 1.61B 55% F 64% D

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

What to not like:
Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Poor return on assets

The company management has delivered below median return on assets in the most recent 4 quarters compared to its peers.

Poor capital utilization

The company management has delivered below median return on invested capital in the most recent 4 quarters compared to its peers.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector